Symposium Body Control – Legal Regulatory Perspectives on Biometrics and Biobanks November 2007 ELSA-research initiated by the Research Council of Norway (RCN) Senior adviser Helge Rynning, Division for strategic priorites, RCN

ELSA RESEARCH - RCN  - Ethical, legal and social aspects of biotechnology (ELSA – Norway);  - Functional genomics in Norway (FUGE)  - Nanotechnology and new materials, nanoscience and integration (NANOMAT)  Ethical, legal and social aspects of biotechnology, nanotechnology and cognitive science ( )

ELSA II ( )  Planning group, report June 2007  Steering Committee appointed, international profile  Programme plan Spring 2008

Planning group, research challenges  Science, technology and society  Democracy, justice and power  Language, dissemination,dialogue  Governance and priorities  Medicine and health: Prevention, enhancement and design  Food,environment and nature  Privacy, consent  Risk, precautionary principle

Programme Board  (Chair) Geir Gogstad, Ph.D.; Department Head, Rikshospitalet-Radiumhospitalet Medical Centre  Professor Peter Aleström, Norwegian School of Veterinary Science  Professor Rigmor Austgulen, Norwegian University of Science and Technology (NTNU)  Professor Ruth Chadwick, Cardiff University; Director of CESAGen (Centre for Economic and Social Aspects of Genomics), Wales  Professor Richard A.L. Jones, University of Sheffield, England

Programme Board (cont)  Fabrice Lapique, Research Manager, SINTEF Materials and Chemistry  Professor Arie Rip, University of Twente, The Netherlands  Associate Professor Andreas Roepstorff, University of Århus, Denmark  Professor Henriette Sinding Aasen, University of Bergen  Dr. Ilina Singh, London School of Economics and Political Science, England